Korea Investment Corp’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Korea Investment Corp’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-46,000	Closed	-$5.18M	–	668
2017 Q3	$5.18M	Sell	46,000 -18,200	-28%	-$1.98M	0.02%	449
2017 Q2	$7.19M	Sell	64,200 -10,400	-14%	-$1.17M	0.03%	386
2017 Q1	$8.7M	Sell	74,600 -15,200	-17%	-$1.68M	0.04%	365
2016 Q4	$9.45M	Buy	89,800 +14,000	+18%	+$1.47M	0.05%	335
2016 Q3	$8.38M	Buy	75,800 +11,200	+17%	+$1.48M	0.04%	342
2016 Q2	$9.41M	Buy	64,600 +31,100	+93%	+$4.41M	0.06%	312
2016 Q1	$4.8M	Buy	33,500 +11,600	+53%	+$1.65M	0.04%	359
2015 Q4	$3.38M	Buy	+21,900	New	+$3.2M	0.02%	423

Other funds holding TARO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fort LP Chevy Chase, Maryland $39.6M AUM 37.11% 1-Year Est. Return

Korea Investment Corp's TARO Position: Q4 2017 in Review

Korea Investment Corp sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2017, closing a stake of 46,000 shares — an estimated $5.18M sold.

Korea Investment Corp first reported a position in TARO in Q4 2015 and held it in 8 quarters. The position peaked at $9.45M in Q4 2016. 127 funds tracked by Wall St. Rank hold TARO as of Q4 2017.

Korea Investment Corp reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2017 after selling out during the quarter.
Korea Investment Corp sold 46,000 Taro Pharmaceutical Industries Ltd. shares in Q4 2017, an estimated $5.18M.
Korea Investment Corp first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2015 and held it in 8 quarters.
Korea Investment Corp's Taro Pharmaceutical Industries Ltd. position peaked at $9.45M in Q4 2016.
127 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2017.

Based on Korea Investment Corp's 13F filing for Q4 2017, filed 12 Feb 2018.